_1777352142843_145525226.png&w=64&q=75){kind=small}
Drug Authority Implements New Pricing System
The Egyptian Drug Authority has adopted a new mechanism for determining and pricing medicines that monitors and adjusts based on three main indicators: exchange rate, inflation, and interest rates. Greater weight is given to exchange rate fluctuations (60%), and the formula is applied every six months with the condition that prices increase or decrease by at least 10%, with changes continuing for a period of 45 days. The mechanism also allows for a 10% reduction in medicine prices if the same conditions are met, with a periodic review of each company every three months. Price re-evaluations are based on an analysis of production costs, reference markets, and economic studies. Additionally, the authority has set profit margins for distributors and pharmacists depending on the type and price of the medication, aiming to monitor and regulate the pharmaceutical market after 15 years since the last regulatory mechanism. This aims to accommodate changes in production costs and currency exchange rates to ensure the availability of modern medicines at appropriate prices.
Notice: This Is an AI-Generated Summary
Comments (0)